plethora solutions holdings (PLE:London)
Financial Statements for plethora solutions holdings (PLE)
| Currency in Millions of British Pounds | As of: | Dec 31 2008 Restated GBP | Dec 31 2009 Reclassified GBP | Dec 31 2010 GBP | Dec 31 2011 GBP | 4 Year Trend |
| Revenues | 0.6 | 17.7 | 1.1 | 0.2 | ![]() ![]() ![]() ![]() | |
| TOTAL REVENUES | 0.6 | 17.7 | 1.1 | 0.2 | ![]() ![]() ![]() ![]() | |
| Cost of Goods Sold | -- | -- | 0.0 | 0.1 | ![]() ![]() ![]() ![]() | |
| GROSS PROFIT | 0.6 | 17.7 | 1.1 | 0.0 | ![]() ![]() ![]() ![]() | |
| Selling General & Admin Expenses, Total | 2.5 | 1.9 | 2.2 | 2.6 | ![]() ![]() ![]() ![]() | |
| R&D Expenses | 9.2 | 6.0 | 0.6 | 0.2 | ![]() ![]() ![]() ![]() | |
| Other Operating Expenses | -- | -- | -0.1 | 0.0 | ![]() ![]() ![]() ![]() | |
| OTHER OPERATING EXPENSES, TOTAL | 11.7 | 8.0 | 2.7 | 2.7 | ![]() ![]() ![]() ![]() | |
| OPERATING INCOME | -11.1 | 9.8 | -1.6 | -2.7 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| Interest Expense | -0.5 | -0.4 | -0.5 | -0.5 | ![]() ![]() ![]() ![]() | |
| Interest and Investment Income | 0.0 | 0.0 | 0.0 | 0.0 | ![]() ![]() ![]() ![]() | |
| NET INTEREST EXPENSE | -0.5 | -0.4 | -0.5 | -0.5 | ![]() ![]() ![]() ![]() | |
| Currency Exchange Gains (Loss) | -2.5 | -0.3 | -- | -- | ![]() ![]() ![]() ![]() | |
| Other Non-Operating Income (Expenses) | 0.0 | 0.0 | 0.0 | 0.1 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| EBT, EXCLUDING UNUSUAL ITEMS | -14.1 | 9.1 | -2.1 | -3.1 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| Other Unusual Items, Total | -- | -- | 0.6 | -1.7 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| Other Unusual Items | -- | -- | 0.6 | -1.7 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| EBT, INCLUDING UNUSUAL ITEMS | -14.1 | 9.1 | -1.5 | -4.9 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| Income Tax Expense | -0.8 | -0.3 | -0.1 | -- | ![]() ![]() ![]() ![]() | |
| Earnings from Continuing Operations | -13.3 | 9.4 | -1.4 | -4.9 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| EARNINGS FROM DISCOUNTINUED OPERATIONS | -3.1 | 0.2 | -- | -- | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| NET INCOME | -16.4 | 9.6 | -1.4 | -4.9 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| NET INCOME TO COMMON INCLUDING EXTRA ITEMS | -16.4 | 9.6 | -1.4 | -4.9 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| NET INCOME TO COMMON EXCLUDING EXTRA ITEMS | -13.3 | 9.4 | -1.4 | -4.9 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| Recently Viewed | |||
| PLE:LN | 1.55 GBp | 0.00 | |
| Company | Last | Change |
| Tribute Pharmaceuticals Canada Inc | $0.35 USD | +0.01 |
| View Industry Companies | ||
Industry Analysis
PLE
Industry Average
| Valuation | PLE | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 6.7x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 11.4x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02









